Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on Hims & Hers Health: Unlocking A $6 Billion Future (NYSE:HIMS) - Seeking Alpha

Hims & Hers Health: Unlocking A $6 Billion Future (NYSE:HIMS)  Seeking Alpha

Hims & Hers Health: Unlocking A $6 Billion Future (NYSE:HIMS) - Seeking Alpha

Click here to get full coverage on Hims & Hers plans Canada expansion to time patent cliff for Novo’s Weogvy - Seeking Alpha

Hims & Hers plans Canada expansion to time patent cliff for Novo’s Weogvy  Seeking Alpha

Hims & Hers plans Canada expansion to time patent cliff for Novo’s Weogvy - Seeking Alpha

Click here to get full coverage on Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses - CNBC

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses  CNBC

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses - CNBC

Click here to get full coverage on Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion - Yahoo Finance

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion  Yahoo Finance

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion - Yahoo Finance

Click here to get full coverage on Nvidia hits $4T, Microsoft upgraded, Hims & Hers in Canada - Yahoo Finance

Nvidia hits $4T, Microsoft upgraded, Hims & Hers in Canada  Yahoo Finance

Nvidia hits $4T, Microsoft upgraded, Hims & Hers in Canada - Yahoo Finance

Click here to get full coverage on Shareholders that lost money on Hims & Hers Health, Inc.(HIMS) should contact The Gross Law Firm about pending Class Action - HIMS - Morningstar

Shareholders that lost money on Hims & Hers Health, Inc.(HIMS) should contact The Gross Law Firm about pending Class Action - HIMS  Morningstar

Shareholders that lost money on Hims & Hers Health, Inc.(HIMS) should contact The Gross Law Firm about pending Class Action - HIMS - Morningstar

Click here to get full coverage on What's Going On With Hims & Hers Health Stock Today? - Benzinga

What's Going On With Hims & Hers Health Stock Today?  Benzinga

What's Going On With Hims & Hers Health Stock Today? - Benzinga

Click here to get full coverage on Market Voices: Copper tariffs, mortgage volumes rise, Hims & Hers - Seeking Alpha

Market Voices: Copper tariffs, mortgage volumes rise, Hims & Hers  Seeking Alpha

Market Voices: Copper tariffs, mortgage volumes rise, Hims & Hers - Seeking Alpha

Click here to get full coverage on Hims ‘Won’t Cave’ to Novo Demands Over Copycat Weight-Loss Shots, CEO Says - Bloomberg.com

Hims ‘Won’t Cave’ to Novo Demands Over Copycat Weight-Loss Shots, CEO Says  Bloomberg.com

Hims ‘Won’t Cave’ to Novo Demands Over Copycat Weight-Loss Shots, CEO Says - Bloomberg.com

Click here to get full coverage on Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future - Los Angeles Times

Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future  Los Angeles Times

Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future - Los Angeles Times

Click here to get full coverage on Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing - PR Newswire

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing  PR Newswire

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing - PR Newswire

Click here to get full coverage on Novo, Hims & Hers engage in war of words after Wegovy deal falls apart - Reuters

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart  Reuters

Novo, Hims & Hers engage in war of words after Wegovy deal falls apart - Reuters

Click here to get full coverage on Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion - Hims & Hers Newsroom

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion  Hims & Hers Newsroom

Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion - Hims & Hers Newsroom

Click here to get full coverage on Hims & Hers’ ugly split with Wegovy maker weighs on the firm’s future - The Seattle Times

Hims & Hers’ ugly split with Wegovy maker weighs on the firm’s future  The Seattle Times

Hims & Hers’ ugly split with Wegovy maker weighs on the firm’s future - The Seattle Times

Click here to get full coverage on Kirby McInerney LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Filing and Encourages Investors to Contact the Firm - Business Wire

Kirby McInerney LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Filing and Encourages Investors to Contact the Firm  Business Wire

Kirby McInerney LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Filing and Encourages Investors to Contact the Firm - Business Wire

Click here to get full coverage on Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - GlobeNewswire

Class Action Filed Against Hims & Hers Health, Inc. (HIMS)  GlobeNewswire

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - GlobeNewswire

Click here to get full coverage on Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices - CBS News

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices  CBS News

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices - CBS News

Click here to get full coverage on Novo Nordisk’s Termination of Hims & Hers Deal Reignites Compounding Row - BioSpace

Novo Nordisk’s Termination of Hims & Hers Deal Reignites Compounding Row  BioSpace

Novo Nordisk’s Termination of Hims & Hers Deal Reignites Compounding Row - BioSpace

Click here to get full coverage on ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS - TradingView

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS  TradingView

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS - TradingView

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit  PR Newswire

Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Click here to get full coverage on Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis - Pharmacy Times

Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis  Pharmacy Times

Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis - Pharmacy Times

Click here to get full coverage on Novo Nordisk and Eli Lilly Slip as Hims Launches Low-Cost Semaglutide Alternative - tastylive

Novo Nordisk and Eli Lilly Slip as Hims Launches Low-Cost Semaglutide Alternative  tastylive

Novo Nordisk and Eli Lilly Slip as Hims Launches Low-Cost Semaglutide Alternative - tastylive

Click here to get full coverage on Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025 - Contact Levi & Korsinsky - ACCESS Newswire

Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025 - Contact Levi & Korsinsky  ACCESS Newswire

Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025 - Contact Levi & Korsinsky - ACCESS Newswire

Click here to get full coverage on HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC  GlobeNewswire

HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Click here to get full coverage on HIMS COURT NOTICE: Hims & Hers Health, Inc. Investors may - GlobeNewswire

HIMS COURT NOTICE: Hims & Hers Health, Inc. Investors may  GlobeNewswire

HIMS COURT NOTICE: Hims & Hers Health, Inc. Investors may - GlobeNewswire

Click here to get full coverage on Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner  Yahoo Finance

Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Click here to get full coverage on Novo Nordisk split puts Hims & Hers future in question - Yahoo Finance

Novo Nordisk split puts Hims & Hers future in question  Yahoo Finance

Novo Nordisk split puts Hims & Hers future in question - Yahoo Finance

Click here to get full coverage on Hims jumps after announcing plans to offer generic Wegovy in Canada in 2026 - Sherwood News

Hims jumps after announcing plans to offer generic Wegovy in Canada in 2026  Sherwood News

Hims jumps after announcing plans to offer generic Wegovy in Canada in 2026 - Sherwood News

Click here to get full coverage on Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds - ABC News - Breaking News, Latest News and Videos

Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds  ABC News - Breaking News, Latest News and Videos

Novo Nordisk ends collaboration with Hims & Hers for discounted weight loss meds - ABC News - Breaking News, Latest News and Videos

Click here to get full coverage on “Expanding Horizons”: Hims & Hers (HIMS) Brings Affordable Weight Loss Program to Canada - TipRanks

“Expanding Horizons”: Hims & Hers (HIMS) Brings Affordable Weight Loss Program to Canada  TipRanks

“Expanding Horizons”: Hims & Hers (HIMS) Brings Affordable Weight Loss Program to Canada - TipRanks

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman - PR Newswire

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman  PR Newswire

Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman - PR Newswire

Click here to get full coverage on Morgan Stanley maintains Hims & Hers stock rating as company plans Canada expansion - Investing.com

Morgan Stanley maintains Hims & Hers stock rating as company plans Canada expansion  Investing.com

Morgan Stanley maintains Hims & Hers stock rating as company plans Canada expansion - Investing.com

Click here to get full coverage on Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34% - CNBC

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%  CNBC

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34% - CNBC

Click here to get full coverage on Novo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop - USA Today

Novo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop  USA Today

Novo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop - USA Today

Click here to get full coverage on Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs - STAT

Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs  STAT

Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs - STAT

Click here to get full coverage on Hims & Hers Stock Plunges 35% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices - Investopedia

Hims & Hers Stock Plunges 35% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices  Investopedia

Hims & Hers Stock Plunges 35% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices - Investopedia

Click here to get full coverage on Hims & Hers' Canadian Play: A Billion-Dollar Bet on Generic GLP-1 and Digital Healthcare Dominance - AInvest

Hims & Hers' Canadian Play: A Billion-Dollar Bet on Generic GLP-1 and Digital Healthcare Dominance  AInvest

Hims & Hers' Canadian Play: A Billion-Dollar Bet on Generic GLP-1 and Digital Healthcare Dominance - AInvest

Click here to get full coverage on Hims & Hers’ stock plunges after Wegovy parent ends weight-loss drug partnership - MarketWatch

Hims & Hers’ stock plunges after Wegovy parent ends weight-loss drug partnership  MarketWatch

Hims & Hers’ stock plunges after Wegovy parent ends weight-loss drug partnership - MarketWatch

Click here to get full coverage on Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It  Yahoo Finance

Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Click here to get full coverage on Hims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal - Fierce Healthcare

Hims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal  Fierce Healthcare

Hims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal - Fierce Healthcare

Click here to get full coverage on Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug - Pharmaceutical Technology

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug  Pharmaceutical Technology

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug - Pharmaceutical Technology

Click here to get full coverage on HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS - TradingView

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS  TradingView

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS - TradingView

Click here to get full coverage on Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup - WSJ - The Wall Street Journal

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup - WSJ  The Wall Street Journal

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup - WSJ - The Wall Street Journal

Click here to get full coverage on Novo Nordisk accuses telehealth company Hims of 'deceptive marketing' and ends Wegovy partnership - Scripps News

Novo Nordisk accuses telehealth company Hims of 'deceptive marketing' and ends Wegovy partnership  Scripps News

Novo Nordisk accuses telehealth company Hims of 'deceptive marketing' and ends Wegovy partnership - Scripps News

Click here to get full coverage on Hims & Hers stock plunges after Novo Nordisk ends its brief partnership - Business Insider

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership  Business Insider

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership - Business Insider

Click here to get full coverage on Novo abruptly ends obesity drug deal with Hims - BioPharma Dive

Novo abruptly ends obesity drug deal with Hims  BioPharma Dive

Novo abruptly ends obesity drug deal with Hims - BioPharma Dive

Click here to get full coverage on Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats - The Hill

Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats  The Hill

Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats - The Hill

Click here to get full coverage on Hims & Hers: Panic Sell Or Opportunistic Buy? - Seeking Alpha

Hims & Hers: Panic Sell Or Opportunistic Buy?  Seeking Alpha

Hims & Hers: Panic Sell Or Opportunistic Buy? - Seeking Alpha

Click here to get full coverage on Hims & Hers stock plunges after Novo Nordisk ends Wegovy direct sales deal - Yahoo Finance

Hims & Hers stock plunges after Novo Nordisk ends Wegovy direct sales deal  Yahoo Finance

Hims & Hers stock plunges after Novo Nordisk ends Wegovy direct sales deal - Yahoo Finance

Click here to get full coverage on How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl - Investor's Business Daily

How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl  Investor's Business Daily

How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl - Investor's Business Daily

Click here to get full coverage on Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer - Hims & Hers Newsroom

Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer  Hims & Hers Newsroom

Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer - Hims & Hers Newsroom

Click here to get full coverage on Going global: expanding Hims & Hers in Europe - Hims & Hers Newsroom

Going global: expanding Hims & Hers in Europe  Hims & Hers Newsroom

Going global: expanding Hims & Hers in Europe - Hims & Hers Newsroom

Click here to get full coverage on Novo Nordisk ends Hims & Hers partnership over GLP-1 safety concerns - TechTarget

Novo Nordisk ends Hims & Hers partnership over GLP-1 safety concerns  TechTarget

Novo Nordisk ends Hims & Hers partnership over GLP-1 safety concerns - TechTarget

Click here to get full coverage on HIMS Stock Crashes 30% in a Day: Time to Buy the Dip? - Yahoo Finance

HIMS Stock Crashes 30% in a Day: Time to Buy the Dip?  Yahoo Finance

HIMS Stock Crashes 30% in a Day: Time to Buy the Dip? - Yahoo Finance

Click here to get full coverage on Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst Questions  Yahoo Finance

Hims Hers Health Inc (HIMS)

Price Chart

Key Statistics

Technicals

About HIMS

Latest News

Hims & Hers Health: Unlocking A $6 Billion Future (NYSE:HIMS) - Seeking Alpha

Hims & Hers plans Canada expansion to time patent cliff for Novo’s Weogvy - Seeking Alpha

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses - CNBC

Advanced Charts

Top Gainers

Top Losers